Unfortunately cancer will continue to be one of the main causes of death and suffering worldwide. In 2005, 7.6 million people died globaly of cancer out of 58 million deaths. Based on WHO's projcetions, the rate will continue to rise, with an estimated 11.4 milion dying in 2030.
In vivo diagnosis, radiotherapy and image guided intervention are just two exemples of areas where Norwegian research excels. This is made possible by a strong research infrastructure and well-regulated healthcare system, including unique biobanks and national cancer registries. Awarded "Norwegian Centre of Expertise" status in 2007, Oslo Cancer Cluster's 40 members have a combined pipeline of close to 50 projects, making it one of the strongest outside the pharmaceutical industry. Now, in what is believed to be the largest investment of its kind, Oslo Cancer Cluster aims to physically integrate research, industry, healthcare provision and even education through the building of the Euro 150 million Oslo Cancer Cluster Innovation park
In order to get a general overview of the activity of Oslo Cancer Cluster please CLICK HERE
 |